SCHEMBL29999839

SCHEMBL29999839

CON(C)C(=O)c1cccnc1Br

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRIM24 O15164 1/20 0.40
TRIM33 Q9UPN9 1/20 0.40
HCRTR1 O43613 1/20 0.39
HCRTR2 O43614 1/20 0.39
NAPRT Q6XQN6 2/20 0.39
TDP1 Q9NUW8 4/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 3/20 0.36
NPSR1 Q6W5P4 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
CYP3A4 P08684 1/20 0.36
MAPT P10636 1/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
BLM P54132 1/20 0.36
AGER Q15109 1/20 0.36
TRPM8 Q7Z2W7 1/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16345329 1.00 TRIM24 (0.40) TRIM24TRIM33HCRTR1HCRTR2NAPRT
SCHEMBL22130586 0.84 ALDH1A1 (0.40) HCRTR1HCRTR2NAPRTTDP1MEN1
SCHEMBL16086240 0.83 SMN1; SMN2 (0.44) TRIM24TRIM33HCRTR1HCRTR2NAPRT
SCHEMBL307472 0.82 P2RX7 (0.50) HCRTR1HCRTR2NAPRTTDP1KDM4E
SCHEMBL781008 0.82 NAPRT (0.56) NAPRTTDP1KMT2AKDM4EALDH1A1
SCHEMBL1092652 0.82 TRPM8 (0.42) HCRTR1HCRTR2NAPRTTDP1KDM4E
SCHEMBL257468 0.81 LMNA (0.54) TDP1MEN1KMT2AL3MBTL1POLB
SCHEMBL306737 0.81 POLB (0.45) HCRTR1HCRTR2NAPRTTDP1ALDH1A1
SCHEMBL29865799 0.81 LMNA (0.54) TDP1MEN1KMT2AL3MBTL1POLB
SCHEMBL3922378 0.78 PARP1 (0.55) TDP1MEN1KMT2AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4320132-A1 OXAZEPINE COMPOUNDS AND USES THEREOF IN THE TREATMENT OF CANCER Genentech, Inc. (US) 2024-02-14 EP disclosed
WO-2022216762-A1 OXAZEPINE COMPOUNDS AND USES THEREOF IN THE TREATMENT OF CANCER GENENTECH, INC. (US) 2022-10-13 WO disclosed